Benitec Biopharma(DE:BJ9)
€3.060.00 (0.00%)
DE:BJ9
Benitec Biopharma earnings date
€3.06
At close:0.00 (0.00%)
Benitec Biopharma (BJ9) Q3 2022 Earnings Report
0 Followers
DE:BJ9 Q3 2022 EPS Results
- Actual EPS
- -EUR 6.15
- Consensus EPS
- -EUR 6.76
- Beat/Miss
- Beat by +EUR 0.61
- One Year Ago EPS
- -EUR 12.65
DE:BJ9 Q3 2022 Revenue Results
- Actual Revenue
- EUR 43.39K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 43.39K
- YoY Revenue Growth
- +4700.00%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 05/16/2022
- Time
- Before Open
- Conference Call
- Monday, May 16, 2022
DE:BJ9 Upcoming Earnings
Benitec Biopharma's next earnings date is estimated for February 15, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BJ9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 15, 2027 | 2027 (Q2) | -0.26- | -0.24 | ― | ― |
| Nov 13, 2026 | 2027 (Q1) | -0.25-0.24 | -0.2 | -18.18% (-0.04) | |
| Sep 14, 2026 | 2026 (Q4) | -0.24-0.24 | -0.37 | 35.80% (+0.13) | |
| May 14, 2026 | 2026 (Q3) | -0.24-0.22 | -0.22 | 0.00% (+0.00) | |
| Feb 12, 2026 | 2026 (Q2) | -0.20-0.24 | -0.3 | 21.21% (+0.06) | |
| Nov 14, 2025 | 2026 (Q1) | -0.41-0.20 | -0.43 | 54.17% (+0.24) | |
| Sep 22, 2025 | 2025 (Q4) | -0.28-0.37 | 0.94 | -138.94% (-1.31) | |
| May 14, 2025 | 2025 (Q3) | -0.31-0.22 | -1.48 | 85.37% (+1.27) | |
| Feb 14, 2025 | 2025 (Q2) | -0.70-0.30 | -2.39 | 87.50% (+2.09) | |
| Nov 14, 2024 | 2025 (Q1) | -0.50-0.43 | -2.49 | 82.61% (+2.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
